These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23344827)

  • 21. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of Mortality in Bloodstream Infections Caused by Pseudomonas aeruginosa and Impact of Antimicrobial Resistance and Bacterial Virulence.
    Recio R; Mancheño M; Viedma E; Villa J; Orellana MÁ; Lora-Tamayo J; Chaves F
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical epidemiology, treatment and prognostic factors of extensively drug-resistant Acinetobacter baumannii ventilator-associated pneumonia in critically ill patients.
    Tsioutis C; Kritsotakis EI; Karageorgos SA; Stratakou S; Psarologakis C; Kokkini S; Gikas A
    Int J Antimicrob Agents; 2016 Nov; 48(5):492-497. PubMed ID: 27542315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment Outcomes for Carbapenem-Resistant and Cephalosporin-Susceptible
    Ng TH; Zhao JJ; Gumbleton R; Olson S; Smith S; Scipione MR
    Ann Pharmacother; 2024 Jun; 58(6):581-588. PubMed ID: 37752788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia.
    Morata L; Cobos-Trigueros N; Martínez JA; Soriano A; Almela M; Marco F; Sterzik H; Núñez R; Hernández C; Mensa J
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4833-7. PubMed ID: 22751533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Five-year trends for ventilator-associated pneumonia: Correlation between microbiological findings and antimicrobial drug consumption.
    Fihman V; Messika J; Hajage D; Tournier V; Gaudry S; Magdoud F; Barnaud G; Billard-Pomares T; Branger C; Dreyfuss D; Ricard JD
    Int J Antimicrob Agents; 2015 Nov; 46(5):518-25. PubMed ID: 26358970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ventilator-Associated Pneumonia due to Drug-Resistant
    Čiginskienė A; Dambrauskienė A; Rello J; Adukauskienė D
    Medicina (Kaunas); 2019 Feb; 55(2):. PubMed ID: 30781896
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
    Arnold HM; Sawyer AM; Kollef MH
    Respir Care; 2012 Aug; 57(8):1226-33. PubMed ID: 22349038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics, risk factors and outcomes of adult cancer patients with extensively drug-resistant Pseudomonas aeruginosa infections.
    Samonis G; Vardakas KZ; Kofteridis DP; Dimopoulou D; Andrianaki AM; Chatzinikolaou I; Katsanevaki E; Maraki S; Falagas ME
    Infection; 2014 Aug; 42(4):721-8. PubMed ID: 24912861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ventilator associated pneumonia due to carbapenem resistant microorganisms in children.
    Kara SS; Polat M; Tapisiz A; Kalkan G; Simsek H; Tezer H
    Minerva Pediatr; 2019 Aug; 71(4):349-357. PubMed ID: 31268280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pseudomonas aeruginosa bacteraemia: independent risk factors for mortality and impact of resistance on outcome.
    Dantas RC; Ferreira ML; Gontijo-Filho PP; Ribas RM
    J Med Microbiol; 2014 Dec; 63(Pt 12):1679-1687. PubMed ID: 25261066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of clinical severity index, infective pathogens, and initial empiric antibiotic use on hospital mortality in patients with ventilator-associated pneumonia.
    Tseng CC; Liu SF; Wang CC; Tu ML; Chung YH; Lin MC; Fang WF
    Am J Infect Control; 2012 Sep; 40(7):648-52. PubMed ID: 22243991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extensively drug-resistant Pseudomonas aeruginosa: risk of bloodstream infection in hospitalized patients.
    Peña C; Gómez-Zorrilla S; Suarez C; Dominguez MA; Tubau F; Arch O; Oliver A; Pujol M; Ariza J
    Eur J Clin Microbiol Infect Dis; 2012 Oct; 31(10):2791-7. PubMed ID: 22552893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbial Etiology and Prognostic Factors of Ventilator-associated Pneumonia: A Multicenter Retrospective Study in Shanghai.
    Huang Y; Jiao Y; Zhang J; Xu J; Cheng Q; Li Y; Liang S; Li H; Gong J; Zhu Y; Song L; Rong Z; Liu B; Jie Z; Sun S; Li P; Wang G; Qu J;
    Clin Infect Dis; 2018 Nov; 67(suppl_2):S146-S152. PubMed ID: 30423049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of the clinical features and outcome of ventilator-associated Pseudomonas aeruginosa-related pneumonia in an intensive care unit].
    Baĭgozina EA; Sovalkin VI; Lukach VN
    Anesteziol Reanimatol; 2009; (2):62-4. PubMed ID: 19514444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and clinical outcomes of episodes of ventilator-associated pneumonia caused by SPM-1-producing and non-producing imipenem-resistant Pseudomonas aeruginosa.
    Furtado GH; Gales AC; Perdiz LB; Santos AF; Medeiros EA
    Rev Soc Bras Med Trop; 2011 Oct; 44(5):604-6. PubMed ID: 22031077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacteriological profile of ventilator-associated pneumonia in a tertiary care hospital.
    Patro S; Sarangi G; Das P; Mahapatra A; Mohapatra D; Paty BP; Chayani N
    Indian J Pathol Microbiol; 2018; 61(3):375-379. PubMed ID: 30004058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and predictors of 14-day mortality in multidrug-resistant Acinetobacter baumannii in ventilator-associated pneumonia.
    Almomani BA; McCullough A; Gharaibeh R; Samrah S; Mahasneh F
    J Infect Dev Ctries; 2015 Dec; 9(12):1323-30. PubMed ID: 26719938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower respiratory tract microbial composition was diversified in Pseudomonas aeruginosa ventilator-associated pneumonia patients.
    Qi X; Qu H; Yang D; Zhou L; He YW; Yu Y; Qu J; Liu J
    Respir Res; 2018 Jul; 19(1):139. PubMed ID: 30049266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Pseudomonas aeruginosa bacteraemia in a tertiary hospital: Mortality and prognostic factors.
    Callejas-Díaz A; Fernández-Pérez C; Ramos-Martínez A; Múñez-Rubio E; Sánchez-Romero I; Vargas Núñez JA
    Med Clin (Barc); 2019 Feb; 152(3):83-89. PubMed ID: 29885868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.